![Angelo Pirozzi: Comprehensive review from Lorenzo Gervaso about Rationale of neoadjuvant immunotherapy in GI malignancies](https://oncodaily.com/pub/uploads/2024/05/1715272824405-e1715451290959.jpeg)
Photo taken from Angelo Pirozzi/LinkedIn
May 25, 2024, 11:14
Angelo Pirozzi: Comprehensive review from Lorenzo Gervaso about Rationale of neoadjuvant immunotherapy in GI malignancies
Angelo Pirozzi, Medical Oncology Fellow at Humanitas University and Research Fellow at Mayo Clinic (Phoenix), made the following post on X:
“Comprehensive review from Lorenzo Gervaso about:
- Rationale of neoadjuvant immunotherapy in GI malignancies
- completed trials in both MSI-H and MSS tumors
- Future perspectives.”
Read further.
Source: Angelo Pirozzi/X
OncoDaily